FDA
-
-
-
-
-
-
-
QURE Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in uniQure N.V. Securities Lawsuit -- The Gross Law Firm
-
-
-
-
-
-
-
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
-
-
-
-
-
-
RBC Capital Upgrades uniQure BV (QURE) to Outperform
-
-
-
-
-
-
-
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
-
-
-
-
-
-
-
RBC Capital Downgrades uniQure BV (QURE) to Sector Perform, Lowers PT to $11
-
-
-
-
-
-
-
uniQure N.V. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - QURE
-
-
-
-
-
-
-
RBC Capita on uniQure BV (QURE): 'The Commissioner's comments are clearly disappointing'
-
322,864 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

